The German group Sartorius, a supplier to the pharmaceutical industry, announced on Friday its intention to acquire the Strasbourg biotechnology company Polyplus, an expert in raw materials used in gene therapy, this process consisting in modifying the expression of certain genes in target cells.
Via its French subsidiary, the group has “signed an agreement to acquire Polyplus for approximately 2.4 billion…
Related posts:
Expert Tips for Safely Dealing with Flooded Roads: How to React and Stay Safe in Torrential Rains
Arkab will lay the first stone on Saturday for the project to exploit the zinc-lead deposit in Bejai...
Largest rocket ever reaches space for the first time, but test still fails | Tech & Science
In 2023, Health Insurance detected 466 million euros of fraud, i.e. 50% more than last year
Anti-waste recipes to save 67 euros per month thanks to the leftovers in your fridge
`` Maru-chan Super Ramen Wantanmen '' sales area expanded nationwide, `` Red Fox '' collaboration ``...
International oil prices fell, subject to the rebound of the dollar, and the supply side also showed...
Cameroon: a new feed factory for poultry farms